Table 5.

ESBL, ciprofloxacin and carbapenem resistance in Gram-negative bacillary by years.

	Hospitalization date		Total
	2008-2012	2013-2018
ESBL, n (%)
ESBL negative	4 (80)	16 (50)	20 (54.1)
ESBL positive	1 (20)	16 (50)	17 (45.9)
Ciprofloxacin, n (%)
Sensitive	2 (40)	19 (57.6)	21 (55.3)
Resistance	3 (60)	14 (42.4)	17 (44.7)
Carbapenem, n (%)
Sensitive	5 (100)	32 (91.4)	37 (92.5)
Resistance	0 (0)	3 (8.6)	3 (7.5)

ESBL: Extended spectrum beta-lactamases.

No statistical comparison was made due to the insufficient number of observations.